These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2690235)

  • 1. Italian multicenter study on the treatment of chronic obstructive lung disease with bromhexine. A double-blind placebo-controlled trial.
    Valenti S; Marenco G
    Respiration; 1989; 56(1-2):11-5. PubMed ID: 2690235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of bromhexine in exacerbations of bronchiectasis. Double-blind randomized multicenter study versus placebo.
    Olivieri D; Ciaccia A; Marangio E; Marsico S; Todisco T; Del Vita M
    Respiration; 1991; 58(3-4):117-21. PubMed ID: 1745841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical results in the treatment of chronic obstructive bronchitis with ambroxol in comparison with bromhexine (author's transl)].
    Wiessmann KJ; Niemeyer K
    Arzneimittelforschung; 1978; 28(5a):918-21. PubMed ID: 373777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
    Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
    Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucolytic treatment in chronic obstructive pulmonary disease. Double-blind comparative clinical trial with N-acetylcysteine, bromhexine and placebo.
    Verstraeten JM
    Acta Tuberc Pneumol Belg; 1979; 70(1):71-80. PubMed ID: 398153
    [No Abstract]   [Full Text] [Related]  

  • 6. Double-blind crossover trial of bromhexine (Bisolvon) in the treatment of chronic bronchitis.
    Armstrong ML
    Med J Aust; 1976 Apr; 1(17):612,614-5,617. PubMed ID: 778563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double blind crossover randomised study of bromhexine in chronic obstructive airway disease.
    Misra MP; Tiwari UC; Chaubal CC; Galhotra R
    J Assoc Physicians India; 1984 May; 32(5):423-5. PubMed ID: 6389491
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mucolytic acitivity of bromhexine guaiacol combination in chronic bronchopneumopathy patients].
    Clini V; Guadagni L; Zennaro M; Fumagalli G
    G Clin Med; 1979 Jun; 60(6):475-89. PubMed ID: 381086
    [No Abstract]   [Full Text] [Related]  

  • 9. A between-patient, double-blind comparison of S-carboxymethylcysteine and bromhexine in chronic obstructive bronchitis.
    Aylward M
    Curr Med Res Opin; 1973; 1(4):219-27. PubMed ID: 4589629
    [No Abstract]   [Full Text] [Related]  

  • 10. Bromhexine in severe asthma.
    Rudolf M; Riordan JF; Grant BJ; Maberly DJ; Saunders KB
    Br J Dis Chest; 1978 Oct; 72(4):307-12. PubMed ID: 365213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled trial of bromhexine ('Bisolvon') in out-patients with chronic bronchitis.
    Lal S; Bhalla KK
    Curr Med Res Opin; 1975; 3(2):63-7. PubMed ID: 1095307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo.
    Olivieri D; Zavattini G; Tomasini G; Daniotti S; Bonsignore G; Ferrara G; Carnimeo N; Chianese R; Catena E; Marcatili S
    Respiration; 1987; 51 Suppl 1():42-51. PubMed ID: 3299567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bromhexine and guaiphenesine on clinical state, ventilatory capacity and sputum viscosity in chronic asthma.
    Heilborn H; Pegelow K-O ; Odeblad E
    Scand J Respir Dis; 1976; 57(2):88-96. PubMed ID: 781835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of bromhexine on levels of netilmicin in serum, saliva, bronchial secretions and bronchial tissue in patients with chronic obstructive pneumopathy].
    Bariffi F; De Marino V; Pisanti N; Sanduzzi A; Giacomelli P; Vatrella A; Gentile A; Capone D
    G Ital Chemioter; 1986; 33(1):67-70. PubMed ID: 3817381
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy, safety and tolerability of salbutamol + guaiphenesin + bromhexine (Ascoril) expectorant versus expectorants containing salbutamol and either guaiphenesin or bromhexine in productive cough: a randomised controlled comparative study.
    Prabhu Shankar S; Chandrashekharan S; Bolmall CS; Baliga V
    J Indian Med Assoc; 2010 May; 108(5):313-4, 316-8, 320. PubMed ID: 21121410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in immunoglobulins in the sputum and serum after the use of secretolytics in patients with chronic obstructive pulmonary disease].
    Prazić B; Acketa M; Obradović-Andelić S; Volf-Pavlović E
    Plucne Bolesti; 1985; 37(3-4):178-82. PubMed ID: 3836422
    [No Abstract]   [Full Text] [Related]  

  • 17. Bromhexine and COPD.
    Gupta SK; Misra K
    J Assoc Physicians India; 1985 Mar; 33(3):250-1. PubMed ID: 4044491
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical efficacy of ambroxol in the treatment of bronchial stasis. Clinical trial in 120 patients at two different doses.
    Germouty J; Jirou-Najou JL
    Respiration; 1987; 51 Suppl 1():37-41. PubMed ID: 3299566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Beeh KM; Beier J; Candler H; Wittig T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Bisolvon in chronic respiratory disease.
    Watson EW
    Med J Aust; 1974 Nov; 2(22):824-5. PubMed ID: 4456160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.